Neonious Biotech

Neonious Biotech

Created using Figma
Created using Figma
Neonious Biotech is introducing the Neonious Token (MDSIM) which is intended to incentivize large numbers of people to form the Neonious Network, a group of computers which will perform the molecular dynamics simulations, by distributing newly generated MDSIMs among these people based on the computing power they provide to the cause. With the molecular dynamics simulations, Neonious Biotech will power Alzheimer and dementia research.
Pre-ICO
25 मई 2021
31 अक्तू॰ 2021
41% पूरा कर लिया है
उठाया गया धन - डेटा नहीं
लक्ष्य 250 000.00 USD
टोपी 30 000 000.00 USD
ongoing
  • 1 MDSIM
    =
    0.1 USD
टोकन विवरण
लंगर
MDSIM
कुल आपूर्ति
125000000
टोकन वितरण
80% Token Sale
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
स्वीकृत मुद्राएँ
ETH, USDC
न्यूनतम योगदान
250000
USD
संस्थान के विवरण
पंजीकृत कंपनी का नाम
Neonious Biotech
पंजीकृत देश
Germany
बोनस संरचना
The price per token starts at 0.10 USD and will, as a minimum, increase by 0.01 USD after every 250,000 ordered tokens, making it worthwhile to buy early.
अतिरिक्त जानकारिया
एमवीपी / प्रोटोटाइप
हाँ
मंच
Ethereum
प्रतिबंधित देश
Cuba, Iran, Lebanon, Libya, Syria, Sudan, Yemen
श्रेणियाँ
मंच

के बारे में Neonious Biotech

We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.

To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.

Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).

Neonious is contracted to help to assess a drug for safety and adverse reactions.

Besides manual analysis, Neonious' research team utilizes computational pipelines

These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.

Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.

This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.

We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.

For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources

तकनीकी जानकारी

https://github.com/neonious/WelcomeToCodeRepository

% नाम% रोडमैप

  • 25/05/2021

  • Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
    ordered, the cheaper the tokens are.
  • 01/07/2021

  • Extensively tested Neonious MD software available on GitHub (source code) and for
    download (Windows, macOS and Linux). May be used on testing network to generate new
    testing tokens.
  • 01/09/2021

  • Neonious MD software and mining contract passed security audit, results are published.
    Neonious Biotech starts the full ICO, preferably with a major exchange.
  • 31/10/2021

  • Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
    anyone on Uniswap by setting up an adequate liquidity pool.
  • और पढो
  • 01/11/2021

  • Neonious Biotech will start helping people set up their systems with the Neonious MD
    software to scale the Neonious Network.
  • 01/01/2022

  • Start of actual molecular dynamic simulations targeting dementia.
  • Early 2022

  • We plan to have reached an agreement for the Neonious Token to be listed at a major
    exchange.

गतिविधि

समर्थक:
164
VERY LOW
ट्वीट:
42
VERY LOW
30 दिन की वृद्धि:
-2
एलेक्सा

श्रेणी:
5 868 559
VERY LOW
डेल्टा:
0
साल करता है:
977
पर नजर रखने वालों:
75
सितारे:
1 243
फोर्क्स:
80
खुले मामले:
55

Neonious Biotech टीम

सत्यापित 0%

ध्यान। एक जोखिम है जो असत्यापित सदस्य वास्तव में टीम के सदस्य नहीं हैं

Thomas Rogg
Chief Executive Officer & Head of Development Team
असत्यापित
Elena Elgina
Head of PR & Marketing
असत्यापित
Maria Cristina Fadgy...
Head of Scientific Affairs
असत्यापित
Martin Kämpf
Head of Digital Assets
असत्यापित

Neonious Biotech अंतिम समाचार

  • क्योंकि सूचना अद्यतन में समय के अंतर हो सकते हैं, प्रत्येक ICO परियोजना के बारे में सटीक जानकारी इसकी आधिकारिक वेबसाइट या अन्य संचार चैनलों के माध्यम से सत्यापित की जानी चाहिए।
  • यह जानकारी ICO फंडिंग में निवेश करने का सुझाव या सलाह नहीं है। कृपया संबंधित जानकारी की पूरी जांच करें और ICO भागीदारी पर निर्णय लें।
  • यदि आपको लगता है कि इस सामग्री पर सुधार किए जाने वाले मुद्दे या समस्याएं हैं, या यदि आप सूचीबद्ध होने के लिए अपनी खुद की ICO परियोजना सबमिट करना चाहते हैं, तो कृपया हमें ईमेल करें । एक>
अस्वीकरण और जोखिम की चेतावनी पढ़ें। अस्वीकरण और जोखिम चेतावनी दिखाएं